Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | PTGDR2 | Q9Y5Y4 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CDC7 | O00311 | 1/20 | 0.44 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18015850 | 0.88 | L3MBTL1 (0.55) | L3MBTL1PTGDR2KDM4EPOLBTRPM8 | |
| SCHEMBL6603353 | 0.87 | L3MBTL1 (0.52) | L3MBTL1PTGDR2KDM4EPOLBTRPM8 | |
| SCHEMBL16398630 | 0.84 | ALOX5 (0.49) | L3MBTL1PTGDR2KDM4EPOLBTRPM8 | |
| SCHEMBL12875849 | 0.83 | DCK (0.46) | L3MBTL1POLBTRPM8ALDH1A1MAPT | |
| SCHEMBL6608210 | 0.83 | PTGDR2 (0.63) | L3MBTL1PTGDR2KDM4EPOLBTRPM8 | |
| SCHEMBL18014741 | 0.81 | L3MBTL1 (0.49) | L3MBTL1PTGDR2KDM4EPOLBTRPM8 | |
| SCHEMBL4034919 | 0.79 | RARA (0.49) | L3MBTL1TRPM8ALDH1A1MAPTCDC7 | |
| SCHEMBL9628554 | 0.79 | TRPM8 (0.62) | L3MBTL1PTGDR2TRPM8MAPTCDC7 | |
| SCHEMBL1198261 | 0.79 | MEN1 (0.54) | L3MBTL1ALDH1A1MAPT | |
| SCHEMBL18003854 | 0.78 | DCK (0.59) | L3MBTL1TRPM8MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1102757-B1 | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS | GLAXO GROUP LTD (GB) | 2004-04-14 | — | — | EP | disclosed |
| US-6498174-B1 | AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME | SMITHKLINE BEECHAM CORPORATION | 2002-12-24 | — | — | US | disclosed |
| EP-1102757-A1 | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000008002-A1 | SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS | GLAXO GROUP LIMITED (GB) | 2000-02-17 | — | — | WO | disclosed |